Jubilant Life Sciences working on reducing its debt through internal accruals against taking fresh loan will serve well for its future growth says Surajit Pal, Prabhudas Lilladher.
first published: Aug 10, 2016 11:36 am
A collection of the most-viewed Moneycontrol videos.
You are already a Moneycontrol Pro user.


